ArticleBMC cancer2021

Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs.

Esther Arnaiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.